Pharmadrug Inc. (PHRX.CN)
CAD 0.01
(0.0%)
CAD 0.01
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 2.92 Million CAD | -10.73% |
| 2022 | 3.27 Million CAD | 23.42% |
| 2021 | 2.65 Million CAD | -14.83% |
| 2020 | 3.11 Million CAD | -47.34% |
| 2019 | 5.92 Million CAD | 281.31% |
| 2018 | 1.55 Million CAD | 7242.44% |
| 2017 | 21.14 Thousand CAD | -70.63% |
| 2016 | 71.99 Thousand CAD | -1.02% |
| 2015 | 72.74 Thousand CAD | -89.47% |
| 2014 | 690.87 Thousand CAD | 464.02% |
| 2013 | 122.49 Thousand CAD | -25.12% |
| 2012 | 163.59 Thousand CAD | 0.0% |
| 2011 | - CAD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 2.01 Million CAD | -8.08% |
| 2024 Q1 | 2.19 Million CAD | -24.92% |
| 2023 Q3 | 3.69 Million CAD | 1.5% |
| 2023 Q2 | 3.64 Million CAD | 9.46% |
| 2023 Q4 | 2.92 Million CAD | -20.9% |
| 2023 FY | 2.92 Million CAD | -10.73% |
| 2023 Q1 | 3.32 Million CAD | 1.58% |
| 2022 Q1 | 2.65 Million CAD | 0.14% |
| 2022 Q3 | 3.2 Million CAD | 5.36% |
| 2022 Q4 | 3.27 Million CAD | 2.28% |
| 2022 FY | 3.27 Million CAD | 23.42% |
| 2022 Q2 | 3.04 Million CAD | 14.38% |
| 2021 Q2 | 2.08 Million CAD | -11.67% |
| 2021 Q4 | 2.65 Million CAD | 42.2% |
| 2021 FY | 2.65 Million CAD | -14.83% |
| 2021 Q1 | 2.36 Million CAD | -24.21% |
| 2021 Q3 | 1.86 Million CAD | -10.54% |
| 2020 Q1 | 5.71 Million CAD | -3.39% |
| 2020 Q2 | 7.02 Million CAD | 22.84% |
| 2020 Q3 | 4.27 Million CAD | -39.11% |
| 2020 Q4 | 3.11 Million CAD | -27.13% |
| 2020 FY | 3.11 Million CAD | -47.34% |
| 2019 Q2 | 5.28 Million CAD | 170.54% |
| 2019 Q4 | 5.92 Million CAD | 57.33% |
| 2019 FY | 5.92 Million CAD | 281.31% |
| 2019 Q1 | 1.95 Million CAD | 25.93% |
| 2019 Q3 | 3.76 Million CAD | -28.86% |
| 2018 FY | 1.55 Million CAD | 7242.44% |
| 2018 Q4 | 1.55 Million CAD | 16.34% |
| 2018 Q3 | 1.33 Million CAD | 535.48% |
| 2018 Q2 | 210 Thousand CAD | 55.18% |
| 2018 Q1 | 135.33 Thousand CAD | 136.72% |
| 2017 Q1 | 153.96 Thousand CAD | 30.76% |
| 2017 Q2 | 31.86 Thousand CAD | -79.3% |
| 2017 Q3 | 21.14 Thousand CAD | -33.64% |
| 2017 Q4 | 57.17 Thousand CAD | 170.37% |
| 2017 FY | 21.14 Thousand CAD | -70.63% |
| 2016 Q1 | 80.59 Thousand CAD | 3.87% |
| 2016 FY | 71.99 Thousand CAD | -1.02% |
| 2016 Q3 | 71.99 Thousand CAD | 96.13% |
| 2016 Q2 | 36.71 Thousand CAD | -54.45% |
| 2016 Q4 | 117.74 Thousand CAD | 63.53% |
| 2015 Q1 | 122.39 Thousand CAD | -65.33% |
| 2015 Q4 | 77.59 Thousand CAD | 6.67% |
| 2015 FY | 72.74 Thousand CAD | -89.47% |
| 2015 Q2 | 112.72 Thousand CAD | -7.9% |
| 2015 Q3 | 72.74 Thousand CAD | -35.47% |
| 2014 Q1 | 187.36 Thousand CAD | -40.59% |
| 2014 FY | 690.87 Thousand CAD | 464.02% |
| 2014 Q2 | 258.58 Thousand CAD | 38.01% |
| 2014 Q3 | 690.87 Thousand CAD | 167.17% |
| 2014 Q4 | 353.04 Thousand CAD | -48.9% |
| 2013 FY | 122.49 Thousand CAD | -25.12% |
| 2013 Q2 | 18.55 Thousand CAD | -61.15% |
| 2013 Q1 | 47.76 Thousand CAD | 92.06% |
| 2013 Q3 | 122.49 Thousand CAD | 560.16% |
| 2013 Q4 | 315.35 Thousand CAD | 157.45% |
| 2012 Q1 | 151.39 Thousand CAD | -27.2% |
| 2012 Q2 | 141.45 Thousand CAD | -6.57% |
| 2012 Q3 | 163.59 Thousand CAD | 15.65% |
| 2012 Q4 | 24.86 Thousand CAD | -84.8% |
| 2012 FY | 163.59 Thousand CAD | 0.0% |
| 2011 Q4 | 207.97 Thousand CAD | 0.0% |
| 2011 FY | - CAD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Aion Therapeutic Inc. | 2.93 Million CAD | 0.376% |
| Ayurcann Holdings Corp. | 14.31 Million CAD | 79.569% |
| Blueberries Medical Corp. | 470.72 Thousand CAD | -521.484% |
| The BC Bud Corporation | 626 Thousand CAD | -367.324% |
| BioNxt Solutions Inc. | 6.55 Million CAD | 55.338% |
| CordovaCann Corp. | 11.29 Million CAD | 74.09% |
| Christina Lake Cannabis Corp. | 8.5 Million CAD | 65.587% |
| Captor Capital Corp. | 28.76 Million CAD | 89.83% |
| City View Green Holdings Inc. | 3.73 Million CAD | 21.632% |
| 1CM Inc. | 9.42 Million CAD | 68.956% |
| Global Hemp Group Inc. | 5.82 Million CAD | 49.779% |
| Greenway Greenhouse Cannabis Corporation | 21.17 Million CAD | 86.184% |
| IM Cannabis Corp. | 35.11 Million CAD | 91.668% |
| Lobe Sciences Ltd. | 2.45 Million CAD | -18.94% |
| Maple Leaf Green World Inc. | 10.08 Million CAD | 70.98% |
| Mountain Valley MD Holdings Inc. | 258 Thousand CAD | -1033.903% |
| Nextleaf Solutions Ltd. | 4.4 Million CAD | 33.563% |
| Ovation Science Inc. | 728.99 Thousand CAD | -301.303% |
| Captiva Verde Wellness Corp. | 2.08 Million CAD | -40.045% |
| RAMM Pharma Corp. | 2.83 Million CAD | -3.173% |
| RIV Capital Inc. | 275.63 Million CAD | 98.939% |
| Revive Therapeutics Ltd. | 3.4 Million CAD | 14.056% |
| Red White & Bloom Brands Inc. | 364.63 Million CAD | 99.198% |
| SLANG Worldwide Inc. | 37.58 Million CAD | 92.216% |
| 1933 Industries Inc. | 23.28 Million CAD | 87.435% |
| Red Light Holland Corp. | 3.82 Million CAD | 23.45% |
| Top Strike Resources Corp. | 20.99 Million CAD | 86.065% |
| Xebra Brands Ltd. | 789.95 Thousand CAD | -270.334% |
| Adastra Holdings Ltd. | 17.65 Million CAD | 83.432% |